Untying the Gordian knot of pericardial diseases: A pragmatic approach

Hellenic Journal of Cardiology

Volumn 57, Issue 5, 2016, Pages 315-322

  Lazaros, George ^a   Imazio, Massimo ^b   Brucato, Antonio ^c   Tousoulis, Dimitrios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF TURIN   (Italy)

^c PAPA GIOVANNI XXIII HOSPITAL   (Italy)

Author keywords

Acute pericarditis; Pericardial constriction; Pericardial effusion; Prognosis; Recurrent pericarditis

Indexed keywords

ACETYLSALICYLIC ACID; ANAKINRA; AZATHIOPRINE; C REACTIVE PROTEIN; CALCIUM; COLCHICINE; CORTICOSTEROID; ETIDRONIC ACID; GADOLINIUM; IBUPROFEN; IMMUNOGLOBULIN; INDOMETACIN; PREDNISONE; VITAMIN D;

CLINICAL TRIAL (TOPIC); HEART TAMPONADE; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; PERICARDIAL DISEASE; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PERICARDITIS; PHYSICAL ACTIVITY; PROGNOSIS; REVIEW; SCORING SYSTEM; SYSTEMATIC REVIEW (TOPIC); CONSTRICTIVE PERICARDITIS; DISEASE MANAGEMENT;

CARDIAC TAMPONADE; CLINICAL TRIALS AS TOPIC; DISEASE MANAGEMENT; HUMANS; PERICARDIAL EFFUSION; PERICARDITIS; PERICARDITIS, CONSTRICTIVE; PROGNOSIS;

EID: 85017536652     PISSN: 11099666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hjc.2016.11.024     Document Type: Review

References (48)

1. Lazaros G, Vlachopoulos C, Stefanadis C. Idiopathic recurrent pericarditis: searching for Ariadne’s thread. Hellenic J Cardiol. 2009;50(3):45-351.
2. Maisch B, Seferovic PM, Ristic AD, et al. Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial diseases executive summary. Eur Heart J. 2004;25:587-610.
3. Imazio M, Adler Y. Pharmacological therapy of pericardial diseases. Curr Pharm Des. 2015;21:525-530.
4. Imazio M, Spodick DH, Brucato A, Trinchero R, Adler Y. Controversial issues in the management of pericardial diseases. Circulation. 2010;121:916-928.
5. Imazio M, Gaita F. Diagnosis and treatment of pericarditis. Heart. 2015;101:1159-1168.
6. Imazio M, Demichelis B, Parrini I, et al. Day-hospital treatment of acute pericarditis: a management program for outpatient therapy. J Am Coll Cardiol. 2004;43:1042-1046.
7. Imazio M, Brucato A, Maestroni S, et al. Prevalence of Creactive protein elevation and time course of normalization in acute pericarditis: implications for the diagnosis, therapy, and prognosis of pericarditis. Circulation. 2011;123:1092-1097.
8. Cosyns B, Plein S, Nihoyanopoulos P, et al. European Association of Cardiovascular Imaging (EACVI) position paper: multimodality imaging in pericardial disease. Eur Heart J Cardiovasc Imaging. 2015;16:12-31.
9. Doulaptsis C, Cazacu A, Dymarkowski S, Goetschalckx K, Bogaert J. Epistenocardiac pericarditis. Hellenic J Cardiol. 2013;54:466-468.
10. Lazaros G, Vlachopoulos C, Stefanadis C. Extensive infectious panel testing for acute pericarditis: a ghost hunt? Cardiology. 2011;119:131-133.
11. Imazio M. Contemporary management of pericardial diseases. Curr Opin Cardiol. 2012;27:308-317.
12. Imazio M, Brucato A, Cemin R, et al. A randomized trial of colchicine for acute pericarditis. N Engl J Med. 2013;369: 1522-1528.
13. Imazio M, Brucato A, Trinchero R, Spodick D, Adler Y. Colchicine for pericarditis: hype or hope? Eur Heart J. 2009;30:532-539.
14. Grossman JM, Gordon R, Ranganath VK, et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken). 2010;62:1515-1526.
15. Imazio M, Brucato A, Maestroni S, et al. Risk of constrictive pericarditis after acute pericarditis. Circulation. 2011;124: 1270-1275.
16. Imazio M. Idiopathic recurrent pericarditis as an immunemediated disease: current insights into pathogenesis and emerging treatment options. Expert Rev Clin Immunol. 2014; 10:1487-1492.
17. Risti_c AD, Imazio M, Adler Y, et al. Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2014;35:2279-2284.
18. Imazio M. Treatment of recurrent pericarditis. Expert Rev Cardiovasc Ther. 2012;10:1165-1172.
19. Cantarini L, Imazio M, Brucato A, Lucherini OM, Galeazzi M. Innate versus acquired immune response in the pathogenesis of recurrent idiopathic pericarditis. Autoimmun Rev. 2010;9:436-440.
20. Lazaros G, Karavidas A, Spyropoulou M, et al. The role of the immunogenetic backgound in the development and recurrence of acute idiopathic pericarditis. Cardiology. 2011;118:55-62.
21. Cantarini L, Imazio M, Brizi MG, et al. Role of autoimmunity and autoinflammation in the pathogenesis of idiopathic recurrent pericarditis. Clin Rev Allergy Immunol. 2013;44:6-13.
22. Cantarini L, Lucherini OM, Brucato A, et al. Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of amulticentre study. Clin Res Cardiol. 2012;101:525-531.
23. Brucato A, Brambilla G, Moreo A, et al. Long-term outcomes in difficult-to-treat patients with recurrent pericarditis. Am J Cardiol. 2006;98:267-271.
24. LeWinter MM. Acute pericarditis. N Engl J Med. 2014;371: 2410-2416.
25. Lilly LS. Treatment of acute and recurrent idiopathic pericarditis. Circulation. 2013;127:1723-1726.
26. Imazio M, Bobbio M, Cecchi E, et al. Colchicine as first choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Arch Intern Med. 2005;165:1987-1991.
27. Imazio M, Brucato A, Cemin R, et al. Colchicine for recurrent pericarditis (CORP): a randomized trial. Ann Intern Med. 2011; 155:409-414.
28. Imazio M, Belli R, Brucato A, et al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial. Lancet. 2014;383:2232-2237.
29. Vianello F, Cinetto F, Cavraro M, et al. Azathioprine in isolated recurrent pericarditis: a single centre experience. Int J Cardiol. 2011;147:477-478.
30. Lazaros G, Vasileiou P, Koutsianas C, et al. Anakinra for the management of resistant idiopathic recurrent pericarditis. Initial experience in 10 adult cases. Ann Rheum Dis. 2014;73: 2215-2217.
31. Vassilopoulos D, Lazaros G, Tsioufis C, Vasileiou P, Stefanadis C, Pectasides D. Successful treatment of adult patients with idiopathic recurrent pericarditis with an interleukin-1 receptor antagonist (anakinra). Int J Cardiol. 2012;160:66-68.
32. Lazaros G, Imazio M, Brucato A, et al. Anakinra: an emerging option for refractory idiopathic recurrent pericarditis. A systematic review of published evidence. J Cardiovasc Med (Hagerstown). 2016;17:256-262.
33. Lazaros G, Tousoulis D. Rheumatoid Arthritis and Atherosclerosis: Could Common Pathogenesis Translate Into Common Therapies? Hellenic J Cardiol. 2015;56:414-417.
34. Imazio M, Lazaros G, Picardi E, et al. Intravenous human immunoglobulins for refractory recurrent pericarditis. a systematic review of all published cases. J Cardiovasc Med (Hagerstown). 2016;17:263-269.
35. Khandaker MH, Schaff HV, Greason KL, et al. Pericardiectomy vs medical management in patients with relapsing pericarditis. Mayo Clin Proc. 2012;87:1062-1070.
36. Lazaros G, Stefanadis C. Malignant pericardial effusion: still a long way to Ithaca. Cardiology. 2013;125:15-17.
37. Imazio M, Brucato A, Adler Y, et al. Prognosis of idiopathic recurrent pericarditis as determined from previously published reports. Am J Cardiol. 2007;100:1026-1028.
38. Vasileiou P, Tsioufis C, Lazaros G, et al. Interleukin-8 as a predictor of acute idiopathic pericarditis recurrences. A pilot study. Int J Cardiol. 2014;172:e463ee464.
39. Welch TD, Ling LH, Espinosa RE, et al. Echocardiographic diagnosis of constrictive pericarditis: Mayo Clinic criteria. Circ Cardiovasc Imaging. 2014;7:526-534.
40. Talreja DR, Edwards WD, Danielson GK, et al. Constrictive pericarditis in 26 patients with histologically normal pericardial thickness. Circulation. 2003;108:1852-1857.
41. Barbetakis N, Xenikakis T, Paliouras D, et al. Pericardiectomy for radiation-induced constrictive pericarditis. Hellenic J Cardiol. 2010;51:214-218.
42. Hoit BD. Management of effusive and constrictive pericardial heart disease. Circulation. 2002;105:2939-2942.
43. Sagristá-Sauleda J, Permanyer-Miralda G, Candell-Riera J, Angel J, Soler-Soler J. Transient cardiac constriction: an unrecognized pattern of evolution in effusive acute idiopathic pericarditis. Am J Cardiol. 1987;59:961-966.
44. Haley JH, Tajik AJ, Danielson GK, Schaff HV, Mulvagh SL, Oh JK. Transient constrictive pericarditis: causes and natural history. J Am Coll Cardiol. 2004;43:271-275.
45. Feng D, Glockner J, Kim K, et al. Cardiac magnetic resonance imaging pericardial late gadolinium enhancement and elevated inflammatory markers can predict the reversibility of constrictive pericarditis after antiinflammatory medical therapy: a pilot study. Circulation. 2011;124:1830-1837.
46. Mitiku TY, Heidenreich PA. A small pericardial effusion is a marker of increased mortality. Am Heart J. 2011;161:152-157.
47. Lazaros G, Imazio M, Tousoulis D. Percutaneous pericardiocentesis: safety first!. Cardiology. 2015;130:34-36.
48. Sagristá-Sauleda J, Angel J, Permanyer-Miralda G, Soler-Soler J. Long-term follow-up of idiopathic chronic pericardial effusion. N Engl J Med. 1999;341:2054-2059.